- Home
- / Pangen Biotech
Pangen Biotech
Stock Price
₩4.9 K
2024-10-29
Market Capitalization
₩56 B
2024-10-29
Revenue
₩14.7 B
FY, 2024
Pangen Biotech Summary
Company Summary
- Overview
- Pangen Biotech ((주)팬젠) is a manufacturer of biologics products. It offers PANPOTIN, a biosimilar epoetin, PGA40, a recombinant factor, PCH250, a biosimilar aflibercept, reagents, and other products.
- Type
- Public
- Status
- Active
- Founded
- 1999
- HQ
- Suwon, KR | view all locations
- Website
- http://www.pangen.com
- Cybersecurity rating
Table of Contents
Key People
LocationsView all
1 location detected
Suwon, Gyeonggi-do HQ
Korea (Republic of)
306 Sinwon-ro, Woncheon-dong, Yeongtong Innoplex 2nd Building, 4th floor
Pangen Biotech Financials
Summary Financials
- Revenue (Q3, 2025)
- ₩4.0B
- Gross profit (Q3, 2025)
- ₩1.3B
- Net income (Q3, 2025)
- ₩531.9M
- Cash (Q3, 2025)
- ₩3.2B
- EBIT (Q3, 2025)
- ₩395.7M
- Enterprise value
- $53.8B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026